{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:10:32Z","timestamp":1792426232383,"version":"4.5.0"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The immunosuppressive tumor microenvironment (TME) is a principal factor limiting the success of current cancer immunotherapies. Immunogenic cell death (ICD), a process whereby dying tumor cells elicit an adaptive immune response through the emission of damage-associated molecular patterns (DAMPs), offers a promising strategy to counteract this limitation. Natural products (NPs) constitute a valuable reservoir of compounds capable of triggering ICD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This review aims to provide a comprehensive overview of ICD inducers derived from NPs, detail their molecular mechanisms of action, and explore their capacity to remodel the immunosuppressive TME.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a comprehensive literature search in relevant electronic databases to identify studies describing NPs-based components that stimulate characteristic ICD markers, such as surface exposure of calreticulin (CRT), and extracellular release of ATP and high mobility group box 1 (HMGB1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Active components of NPs were demonstrated to initiate ICD largely via the induction of endoplasmic reticulum (ER) stress and reactive oxygen species (ROS). The consequent emission of DAMPs facilitates dendritic cell-mediated phagocytosis of tumor antigens and the priming of cytotoxic T lymphocytes. Additionally, the inflammatory milieu generated by NPs-induced ICD reprograms the TME by promoting the repolarization of macrophages to an immunostimulatory M1 phenotype and inhibiting the suppressive functions of myeloid-derived suppressor cells (MDSCs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Inducing ICD with NPs is a viable therapeutic strategy to potentiate anti-tumor immunity. The convergence of NPs-based ICD inducers with nanotechnology-based delivery systems offers a robust platform for the development of innovative combination regimens aimed at improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1745590","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:24:09Z","timestamp":1769513049000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Induction of immunogenic cell death by active components of natural products reshaping the tumor microenvironment for enhanced antitumor immunity"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaojie","family":"Chen","sequence":"first","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine","place":["Jinan, Shandong, China"]},{"name":"Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojia","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfei","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Traditional Chinese Medicine, Binzhou Medical College","place":["Yantai, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Hou","sequence":"additional","affiliation":[{"name":"Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaokun","family":"Tian","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine","place":["Jinan, Shandong, China"]},{"name":"Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Qiu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine","place":["Jinan, Shandong, China"]},{"name":"Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Yu","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College, Shandong University of Traditional Chinese Medicine","place":["Jinan, Shandong, China"]},{"name":"Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute","place":["Jinan, Shandong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1007\/s13346-024-01649-z","article-title":"Natural compounds-based nanomedicines for cancer treatment: future directions and challenges","volume":"14","author":"Andreani","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12041047","article-title":"Current approaches for combination therapy of cancer: the role of immunogenic cell death","volume":"12","author":"Asadzadeh","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1021\/acs.molpharmaceut.2c00455","article-title":"Utility of intravenous curcumin nanodelivery systems for improving in vivo pharmacokinetics and anticancer pharmacodynamics","volume":"19","author":"Bagheri","year":"2022","journal-title":"Mol. Pharm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.cell.2022.03.033","article-title":"Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche","volume":"185","author":"Baldominos","year":"2022","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.trecan.2024.07.010","article-title":"Advances in exosomes utilization for clinical applications in cancer","volume":"10","author":"Batista","year":"2024","journal-title":"Trends Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1124\/dmd.120.000054","article-title":"A new data repository for pharmacokinetic natural product-drug interactions: from chemical characterization to clinical studies","volume":"48","author":"Birer-Williams","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.3390\/cancers14153737","article-title":"Cancer associated fibroblast (CAF) regulation of PDAC parenchymal (CPC) and CSC phenotypes is modulated by ECM composition","volume":"14","author":"Cannone","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41423-024-01245-8","article-title":"Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors","volume":"22","author":"Catanzaro","year":"2025","journal-title":"Cell Mol. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1038\/onc.2011.137","article-title":"Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2","volume":"30","author":"Chen","year":"2011","journal-title":"Oncogene"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00262-012-1258-9","article-title":"Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine","volume":"61","author":"Chen","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"B12","doi-asserted-by":"publisher","first-page":"156107","DOI":"10.1016\/j.phymed.2024.156107","article-title":"Euphorbia pekinensis rupr. sensitizes colorectal cancer to PD-1 blockade by remodeling the tumor microenvironment and enhancing peripheral immunity","volume":"135","author":"Chen","year":"","journal-title":"Phytomedicine"},{"key":"B13","doi-asserted-by":"publisher","first-page":"121643","DOI":"10.1016\/j.carbpol.2023.121643","article-title":"Injectable alginate hydrogel promotes antitumor immunity through glucose oxidase and Fe(3+) amplified RSL3-induced ferroptosis","volume":"326","author":"Chen","year":"","journal-title":"Carbohydr. Polym."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1021\/acsami.4c13433","article-title":"Mitochondria-targeted icaritin nanoparticles induce immunogenic cell death in hepatocellular carcinoma","volume":"17","author":"Chen","year":"2025","journal-title":"ACS Appl. Mater Interfaces"},{"key":"B15","doi-asserted-by":"publisher","first-page":"13513","DOI":"10.1021\/acsnano.2c05379","article-title":"Emerging strategies in stimuli-responsive prodrug nanosystems for cancer therapy","volume":"16","author":"Ding","year":"2022","journal-title":"ACS Nano"},{"key":"B16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12950-021-00289-1","article-title":"Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones","volume":"18","author":"Fan","year":"2021","journal-title":"J. Inflamm. (Lond)."},{"key":"B19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.scib.2020.07.013","article-title":"Polypeptide nanoformulation-induced immunogenic cell death and remission of immunosuppression for enhanced chemoimmunotherapy","volume":"66","author":"Feng","year":"2021","journal-title":"Sci. Bull. (Beijing)"},{"key":"B20","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.7150\/thno.81650","article-title":"Fe(III)-Shikonin supramolecular nanomedicines as immunogenic cell death stimulants and multifunctional immunoadjuvants for tumor vaccination","volume":"13","author":"Feng","year":"2023","journal-title":"Theranostics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/imr.13249","article-title":"Biomarkers of immune checkpoint inhibitor response and toxicity: challenges and opportunities","volume":"318","author":"Goodman","year":"2023","journal-title":"Immunol. Rev."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000337","article-title":"Consensus guidelines for the definition, detection and interpretation of immunogenic cell death","volume":"8","author":"Galluzzi","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s41573-024-00920-9","article-title":"Targeting immunogenic cell stress and death for cancer therapy","volume":"23","author":"Galluzzi","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"B24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/imr.12574","article-title":"Cell death and immunity in cancer: from danger signals to mimicry of pathogen defense responses","volume":"280","author":"Garg","year":"2017","journal-title":"Immunol. Rev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1158\/0008-5472.CAN-23-2812","article-title":"Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-Positive breast cancer","volume":"84","author":"Gedik","year":"2024","journal-title":"Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1466765","DOI":"10.1080\/2162402X.2018.1466765","article-title":"PKR and GCN2 stress kinases promote an ER stress-independent eIF2\u03b1 phosphorylation responsible for calreticulin exposure in melanoma cells","volume":"7","author":"Giglio","year":"2018","journal-title":"Oncoimmunology"},{"key":"B28","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fimmu.2012.00414","article-title":"ATP release and purinergic signaling in NLRP3 inflammasome activation","volume":"3","author":"Gombault","year":"2012","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.semcancer.2019.11.010","article-title":"Nano-immunotherapy: overcoming tumour immune evasion","volume":"69","author":"Guevara","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1038\/s41467-021-25894-9","article-title":"9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy","volume":"12","author":"Han","year":"2021","journal-title":"Nat. Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jconrel.2022.05.057","article-title":"Nano co-delivery of plumbagin and dihydrotanshinone I reverses immunosuppressive TME of liver cancer","volume":"348","author":"Han","year":"2022","journal-title":"J. Control Release"},{"key":"B32","doi-asserted-by":"publisher","first-page":"154682","DOI":"10.1016\/j.phymed.2023.154682","article-title":"Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy","volume":"112","author":"Han","year":"2023","journal-title":"Phytomedicine"},{"key":"B33","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1208\/s12249-014-0211-y","article-title":"Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using box-behnken design","volume":"16","author":"Hao","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e12461","DOI":"10.15252\/emmm.202012461","article-title":"Combination therapies induce cancer cell death through the integrated stress response and disturbed pyrimidine metabolism","volume":"13","author":"Hartleben","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.immuni.2018.03.015","article-title":"KLRG1(+) effector CD8(+) T cells lose KLRG1, differentiate into all memory T cell lineages, and convey enhanced protective immunity","volume":"48","author":"Herndler-Brandstetter","year":"2018","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","first-page":"157085","DOI":"10.1016\/j.phymed.2025.157085","article-title":"Artesunate modulates the tumor microenvironment via STAT1\/IRF1-mediated TAM repolarization and T cell activation in non-small cell lung cancer","volume":"146","author":"Hu","year":"2025","journal-title":"Phytomedicine"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000330","article-title":"A recombinant oncolytic Newcastle virus expressing MIP-3\u03b1 promotes systemic antitumor immunity","volume":"8","author":"Huang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-022-01515-x","article-title":"Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer","volume":"21","author":"Huang","year":"2022","journal-title":"Mol. Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41419-023-06408-5","article-title":"TNF\u03b1 modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer","volume":"15","author":"Huang","year":"2024","journal-title":"Cell Death Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e2415227","DOI":"10.1002\/advs.202415227","article-title":"Mitigating doxorubicin-induced cardiotoxicity and enhancing anti-tumor efficacy with a metformin-integrated self-assembled nanomedicine","volume":"12","author":"Huang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"23231","DOI":"10.1038\/s41598-024-72697-1","article-title":"Induction of immunogenic cell death and enhancement of the radiation-induced immunogenicity by chrysin in melanoma cancer cells","volume":"14","author":"Jafari","year":"2024","journal-title":"Sci. Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"155521","DOI":"10.1016\/j.phymed.2024.155521","article-title":"Salvia miltiorrhiza bunge (Danshen) based nano-delivery systems for anticancer therapeutics","volume":"128","author":"Jia","year":"2024","journal-title":"Phytomedicine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"39303","DOI":"10.1021\/acsnano.5c13557","article-title":"Engineered probiotics remodel the tumor immune microenvironment","volume":"19","author":"Jiang","year":"2025","journal-title":"ACS Nano"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/ptr.7747","article-title":"Traditional medicine herbs as natural product matrices in cancer chemoprevention: a trans pharmacological perspective (scoping review)","volume":"37","author":"Kalachaveedu","year":"2023","journal-title":"Phytother. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"5955","DOI":"10.3390\/molecules28165955","article-title":"Smart targeted delivery systems for enhancing antitumor therapy of active ingredients in traditional Chinese medicine","volume":"28","author":"Kang","year":"2023","journal-title":"Molecules"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e1637188","DOI":"10.1080\/2162402X.2019.1637188","article-title":"Clinical evidence that immunogenic cell death sensitizes to PD-1\/PD-L1 blockade","volume":"8","author":"Kepp","year":"2019","journal-title":"Oncoimmunology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2174\/1568026623666230201145909","article-title":"Tumor-associated macrophages (TAMs) in cancer resistance; modulation by natural products","volume":"23","author":"Lafta","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1158\/2326-6066.CIR-19-0616","article-title":"Paclitaxel induces immunogenic cell death in ovarian cancer via TLR4\/IKK2\/SNARE-Dependent exocytosis","volume":"8","author":"Lau","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"B53","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jconrel.2021.05.040","article-title":"Low dose shikonin and anthracyclines coloaded liposomes induce robust immunogenetic cell death for synergistic chemo-immunotherapy","volume":"335","author":"Li","year":"2021","journal-title":"J. Control Release"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e2201734","DOI":"10.1002\/advs.202201734","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"","journal-title":"Adv. Sci. (Weinh)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jconrel.2022.01.015","article-title":"Codelivery of shikonin and siTGF-\u03b2 for enhanced triple negative breast cancer chemo-immunotherapy","volume":"342","author":"Li","year":"","journal-title":"J. Control Release"},{"key":"B56","doi-asserted-by":"publisher","first-page":"123729","DOI":"10.1016\/j.ijpharm.2023.123729","article-title":"Repolarizing tumor-associated macrophages and inducing immunogenic cell death: a targeted liposomal strategy to boost cancer immunotherapy","volume":"651","author":"Li","year":"2024","journal-title":"Int. J. Pharm."},{"key":"B57","doi-asserted-by":"publisher","first-page":"114895","DOI":"10.1016\/j.colsurfb.2025.114895","article-title":"Construction and evaluation of pH-sensitive nanoparticles with resveratrol release to trigger the immunogenic cell death in colon cancer cellsin vitro","volume":"255","author":"Li","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B58","doi-asserted-by":"publisher","first-page":"122608","DOI":"10.1016\/j.biomaterials.2024.122608","article-title":"Shikonin and chitosan-silver nanoparticles synergize against triple-negative breast cancer through RIPK3-triggered necroptotic immunogenic cell death","volume":"309","author":"Liang","year":"2024","journal-title":"Biomaterials"},{"key":"B59","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/cac2.12327","article-title":"KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1\/PD-L1 immunotherapy in non-small cell lung cancer","volume":"42","author":"Liu","year":"2022","journal-title":"Cancer Commun. (Lond)."},{"key":"B60","doi-asserted-by":"publisher","first-page":"154612","DOI":"10.1016\/j.phymed.2022.154612","article-title":"Natural products targeting macrophages in tumor microenvironment are a source of potential antitumor agents","volume":"109","author":"Liu","year":"","journal-title":"Phytomedicine"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s10528-022-10309-1","article-title":"Isoquercitrin induces endoplasmic reticulum stress and immunogenic cell death in gastric cancer cells","volume":"61","author":"Liu","year":"","journal-title":"Biochem. Genet."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e2201401","DOI":"10.1002\/smtd.202201401","article-title":"Radiation-induced immunogenic cell death for cancer radioimmunotherapy","volume":"7","author":"Liu","year":"","journal-title":"Small Methods"},{"key":"B63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/imr.13269","article-title":"Immunogenic cell death (ICD) enhancers-drugs that enhance the perception of ICD by dendritic cells","volume":"321","author":"Liu","year":"2024","journal-title":"Immunol. Rev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"106973","DOI":"10.1016\/j.phrs.2023.106973","article-title":"Dietary \u03b3-mangostin triggers immunogenic cell death and activates cGAS signaling in acute myeloid leukemia","volume":"197","author":"Long","year":"2023","journal-title":"Pharmacol. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"13168","DOI":"10.1021\/acsnano.2c06300","article-title":"Nanocarrier Co-formulation for delivery of a TLR7 agonist plus an immunogenic cell death stimulus triggers effective pancreatic cancer chemo-immunotherapy","volume":"16","author":"Luo","year":"2022","journal-title":"ACS Nano"},{"key":"B66","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1158\/1078-0432.CCR-22-1591","article-title":"Necroptosis-dependent immunogenicity of cisplatin: implications for enhancing the radiation-induced abscopal effect","volume":"29","author":"Luo","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.7150\/thno.72509","article-title":"Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy","volume":"12","author":"Mao","year":"2022","journal-title":"Theranostics"},{"key":"B68","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12935-022-02585-z","article-title":"Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; combination of oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction","volume":"22","author":"Mardi","year":"2022","journal-title":"Cancer Cell Int."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s13402-024-01009-6","article-title":"Triggering immunogenic death of cancer cells by nanoparticles overcomes immunotherapy resistance","volume":"47","author":"Mei","year":"2024","journal-title":"Cell Oncol. (Dordr)"},{"key":"B70","doi-asserted-by":"publisher","first-page":"115083","DOI":"10.1016\/j.addr.2023.115083","article-title":"Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer","volume":"202","author":"Mikhail","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B71","doi-asserted-by":"publisher","first-page":"e012880","DOI":"10.1136\/jitc-2025-012880","article-title":"PD-L1 phenotype classification based on expression in tumor and immune cells as a potential biomarker for optimizing anti-PD-1\/CTLA-4 immunotherapies in NSCLC","volume":"13","author":"Miyakoshi","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1007\/s00262-022-03216-2","article-title":"Near-infrared photoimmunotherapy induced tumor cell death enhances tumor dendritic cell migration","volume":"71","author":"Moriya","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"B73","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s11095-011-0645-9","article-title":"Novel anti-cancer compounds for developing combinatorial therapies to target anoikis-resistant tumors","volume":"29","author":"Nagaprashantha","year":"2012","journal-title":"Pharm. Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1049888","DOI":"10.3389\/fonc.2022.1049888","article-title":"The function of natural compounds in important anticancer mechanisms","volume":"12","author":"Nan","year":"","journal-title":"Front. Oncol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2021.12.025","article-title":"Tumor-stroma TGF-\u03b21-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin \u03b1(v)\u03b2(3)\/CD36-mediated activation of the MAPK pathway","volume":"528","author":"Nan","year":"","journal-title":"Cancer Lett."},{"key":"B77","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","article-title":"Cancer immunoediting and resistance to T cell-based immunotherapy","volume":"16","author":"O'Donnell","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e009552","DOI":"10.1136\/jitc-2024-009552","article-title":"S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling","volume":"12","author":"\u00d6zbay Kurt","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"E11721","DOI":"10.1073\/pnas.1811432115","article-title":"Molecular mechanisms of biogenesis of apoptotic exosome-like vesicles and their roles as damage-associated molecular patterns","volume":"115","author":"Park","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01635581.2022.2096909","article-title":"Complexity of tumor microenvironment: therapeutic role of curcumin and its metabolites","volume":"75","author":"Prasad","year":"2023","journal-title":"Nutr. Cancer"},{"key":"B81","doi-asserted-by":"publisher","first-page":"113717","DOI":"10.1016\/j.jconrel.2025.113717","article-title":"Hypoxia-responsive oncolytic conjugate triggers type-II immunogenic cell death for enhanced photodynamic immunotherapy","volume":"382","author":"Ren","year":"2025","journal-title":"J. Control Release"},{"key":"B82","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/jamaoncol.2025.1115","article-title":"Neoadjuvant PD-1 and PD-L1 blockade with chemotherapy for borderline resectable and unresectable stage III non-small cell lung cancer","volume":"11","author":"Ricciuti","year":"2025","journal-title":"JAMA Oncol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1021\/acsnano.3c10862","article-title":"A twindrive precise delivery system of platelet-neutrophil hybrid membrane regulates macrophage combined with CD47 blocking for postoperative immunotherapy","volume":"18","author":"Sheng","year":"2024","journal-title":"ACS Nano"},{"key":"B85","doi-asserted-by":"publisher","first-page":"112442","DOI":"10.1016\/j.biopha.2021.112442","article-title":"Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms","volume":"146","author":"Slika","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B86","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4110\/in.2016.16.1.75","article-title":"Immunogenic cell death induced by ginsenoside Rg3: significance in dendritic cell-based anti-tumor immunotherapy","volume":"16","author":"Son","year":"2016","journal-title":"Immune Netw."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2219591","DOI":"10.1080\/2162402X.2023.2219591","article-title":"Trial watch: chemotherapy-induced immunogenic cell death in oncology","volume":"12","author":"Sprooten","year":"2023","journal-title":"Oncoimmunology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"53577","DOI":"10.1021\/acsami.4c12821","article-title":"Dendritic cell-targeted nanoparticles enhance T cell activation and antitumor immune responses by boosting antigen presentation and blocking PD-L1 pathways","volume":"16","author":"Srivastava","year":"2024","journal-title":"ACS Appl. Mater Interfaces"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.3892\/or.2017.5428","article-title":"Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3\/NF-\u03baB pathway","volume":"37","author":"Su","year":"2017","journal-title":"Oncol. Rep."},{"key":"B90","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12943-025-02378-8","article-title":"The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine","volume":"24","author":"Su","year":"2025","journal-title":"Mol. Cancer"},{"key":"B91","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/s41419-022-05319-1","article-title":"Enhanced radiation-induced immunogenic cell death activates chimeric antigen receptor T cells by targeting CD39 against glioblastoma","volume":"13","author":"Sun","year":"2022","journal-title":"Cell Death Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"102216","DOI":"10.1016\/j.mtbio.2025.102216","article-title":"Ultrasound-activated miR-195-5p\/shikonin nanobubbles remodel immunosuppressive microenvironment via immunogenic cell death to potentiate PD-1\/PD-L1 blockade in hepatocellular carcinoma","volume":"34","author":"Tan","year":"","journal-title":"Mater Today Bio"},{"key":"B93","doi-asserted-by":"publisher","first-page":"114242","DOI":"10.1016\/j.jconrel.2025.114242","article-title":"Mitochondria-targeted hybrid nanovesicles trigger immunogenic cell death and remodel tumor neutrophils for enhanced colorectal cancer immunotherapy","volume":"387","author":"Tan","year":"","journal-title":"J. Control Release"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e002787","DOI":"10.1136\/jitc-2021-002787","article-title":"GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma","volume":"9","author":"Wang","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B95","doi-asserted-by":"publisher","first-page":"111044","DOI":"10.1016\/j.biopha.2020.111044","article-title":"Anticancer activities of TCM and their active components against tumor metastasis","volume":"133","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B96","doi-asserted-by":"publisher","first-page":"100304","DOI":"10.1016\/j.mtbio.2022.100304","article-title":"Targeted regulation of tumor microenvironment through the inhibition of MDSCs by curcumin loaded self-assembled nano-filaments","volume":"15","author":"Wang","year":"","journal-title":"Mater Today Bio"},{"key":"B97","doi-asserted-by":"publisher","first-page":"4665","DOI":"10.1021\/acs.molpharmaceut.2c00701","article-title":"Camptothesome potentiates PD-L1 immune checkpoint blockade for improved metastatic triple-negative breast cancer immunochemotherapy","volume":"19","author":"Wang","year":"","journal-title":"Mol. Pharm."},{"key":"B98","doi-asserted-by":"publisher","first-page":"216038","DOI":"10.1016\/j.canlet.2022.216038","article-title":"Immune checkpoint inhibitor resistance in hepatocellular carcinoma","volume":"555","author":"Wang","year":"","journal-title":"Cancer Lett."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e1875","DOI":"10.1002\/wnan.1875","article-title":"Cell surface-nanoengineering for cancer targeting immunoregulation and precise immunotherapy","volume":"15","author":"Wang","year":"","journal-title":"Wiley Interdiscip. Rev. Nanomed Nanobiotechnol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"122570","DOI":"10.1016\/j.biomaterials.2024.122570","article-title":"NIR-responsive copper nanoliposome composites for cascaded ferrotherapy via ferroptosis actived ICD and IFN-\u03b3 released","volume":"308","author":"Wang","year":"","journal-title":"Biomaterials"},{"key":"B101","doi-asserted-by":"publisher","first-page":"155504","DOI":"10.1016\/j.phymed.2024.155504","article-title":"Combining cisplatin with Pinellia pedatisecta schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer","volume":"128","author":"Wang","year":"","journal-title":"Phytomedicine"},{"key":"B102","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12951-024-02727-7","article-title":"Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer","volume":"22","author":"Wang","year":"","journal-title":"J. Nanobiotechnology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1016\/j.apsb.2024.04.010","article-title":"Endoplasmic reticulum-targeted delivery of celastrol and PD-L1 siRNA for reinforcing immunogenic cell death and potentiating cancer immunotherapy","volume":"14","author":"Wang","year":"","journal-title":"Acta Pharm. Sin. B"},{"key":"B104","doi-asserted-by":"publisher","first-page":"122637","DOI":"10.1016\/j.carbpol.2024.122637","article-title":"Fucoidan based Ce6-chloroquine self-assembled hydrogel as in situ vaccines to enhance tumor immunotherapy by autophagy inhibition and macrophage polarization","volume":"346","author":"Wang","year":"","journal-title":"Carbohydr. Polym."},{"key":"B105","doi-asserted-by":"publisher","first-page":"e2309591","DOI":"10.1002\/adma.202309591","article-title":"Synergistic chemoimmunotherapy augmentation via sequential nanocomposite hydrogel-mediated reprogramming of cancer-associated fibroblasts in osteosarcoma","volume":"36","author":"Wang","year":"","journal-title":"Adv. Mater"},{"key":"B106","doi-asserted-by":"publisher","first-page":"120333","DOI":"10.1016\/j.ijpharm.2021.120333","article-title":"Enhancing TNBC Chemo-immunotherapy via combination reprogramming tumor immune microenvironment with immunogenic cell death","volume":"598","author":"Wu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"B107","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12931-023-02443-0","article-title":"An ICD-associated DAMP gene signature predicts survival and immunotherapy response of patients with lung adenocarcinoma","volume":"24","author":"Wu","year":"","journal-title":"Respir. Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/tox.23793","article-title":"Induction of immunogenic cell death effect of licoricidin in cervical cancer cells by enhancing endoplasmic reticulum stress-mediated high mobility group box 1 expression","volume":"38","author":"Wu","year":"","journal-title":"Environ. Toxicol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s12906-023-04221-3","article-title":"Afzelin induces immunogenic cell death against lung cancer by targeting NQO2","volume":"23","author":"Xia","year":"2023","journal-title":"BMC Complement. Med. Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"B113","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41571-023-00789-4","article-title":"Antigen presentation in cancer - mechanisms and clinical implications for immunotherapy","volume":"20","author":"Yang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B114","doi-asserted-by":"publisher","first-page":"117099","DOI":"10.1016\/j.biopha.2024.117099","article-title":"Plant-derived natural compounds: a new frontier in inducing immunogenic cell death for cancer treatment","volume":"177","author":"Yang","year":"","journal-title":"Biomed. Pharmacother."},{"key":"B115","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jconrel.2024.10.043","article-title":"A pH and glutathione-responsive carbon monoxide-driven nano-herb delivery system for enhanced immunotherapy in colorectal cancer","volume":"376","author":"Yang","year":"","journal-title":"J. Control Release"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jconrel.2024.10.060","article-title":"A personalized vaccine combining immunogenic cell death-induced cells and nanosized antigens for enhanced antitumor immunity","volume":"376","author":"Yang","year":"","journal-title":"J. Control Release"},{"key":"B117","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-025-03377-9","article-title":"Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1001\/jamaoncol.2022.5816","article-title":"Effectiveness of immune checkpoint inhibitors in patients with advanced esophageal squamous cell carcinoma: a meta-analysis including low PD-L1 subgroups","volume":"9","author":"Yap","year":"2023","journal-title":"JAMA Oncol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"188946","DOI":"10.1016\/j.bbcan.2023.188946","article-title":"Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy","volume":"1878","author":"Yu","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"B120","doi-asserted-by":"publisher","first-page":"e2311507","DOI":"10.1002\/smll.202311507","article-title":"Self-assembled PD-L1 downregulator to boost photodynamic activated tumor immunotherapy through CDK5 inhibition","volume":"20","author":"Yu","year":"2024","journal-title":"Small"},{"key":"B121","doi-asserted-by":"publisher","first-page":"114353","DOI":"10.1016\/j.jconrel.2025.114353","article-title":"Ultrasound-responsive nanocarriers for cancer therapy: physiochemical features-directed design","volume":"388","author":"Yuan","year":"","journal-title":"J. Control Release"},{"key":"B122","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13020-025-01075-4","article-title":"A new paradigm for drug discovery in the treatment of complex diseases: drug discovery and optimization","volume":"20","author":"Yuan","year":"","journal-title":"Chin. Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.phrs.2019.01.020","article-title":"Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: State-of-the-art","volume":"141","author":"Zangui","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B124","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.actbio.2017.04.029","article-title":"pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities","volume":"58","author":"Zhang","year":"2017","journal-title":"Acta Biomater."},{"key":"B125","doi-asserted-by":"publisher","first-page":"12511","DOI":"10.1021\/acsnano.9b02875","article-title":"Nanoformulated codelivery of quercetin and alantolactone promotes an antitumor response through synergistic immunogenic cell death for microsatellite-stable colorectal cancer","volume":"13","author":"Zhang","year":"2019","journal-title":"ACS Nano"},{"key":"B126","doi-asserted-by":"publisher","first-page":"12044","DOI":"10.7150\/thno.47901","article-title":"ITGB2-mediated metabolic switch in CAFs promotes OSCC proliferation by oxidation of NADH in mitochondrial oxidative phosphorylation system","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"B127","doi-asserted-by":"publisher","first-page":"155828","DOI":"10.1016\/j.phymed.2024.155828","article-title":"Immunogenic cell death inducers for cancer therapy: an emerging focus on natural products","volume":"132","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"B129","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jconrel.2021.05.036","article-title":"Charge-switchable nanoparticles enhance cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction","volume":"335","author":"Zhao","year":"2021","journal-title":"J. Control Release"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e2206932","DOI":"10.1002\/advs.202206932","article-title":"Near-Infrared-II nanoparticles for vascular normalization combined with immune checkpoint blockade via photodynamic immunotherapy inhibit uveal melanoma growth and metastasis","volume":"10","author":"Zheng","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"B131","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2025.07.047","article-title":"Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway","volume":"239","author":"Zheng","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"e1805888","DOI":"10.1002\/adma.201805888","article-title":"Tumor microenvironment-activatable prodrug vesicles for nanoenabled cancer chemoimmunotherapy combining immunogenic cell death induction and CD47 blockade","volume":"31","author":"Zhou","year":"2019","journal-title":"Adv. Mater"},{"key":"B133","doi-asserted-by":"publisher","first-page":"112637","DOI":"10.1016\/j.intimp.2024.112637","article-title":"Dihydroartemisinin remodels tumor micro-environment and improves cancer immunotherapy through inhibiting cyclin-dependent kinases","volume":"139","author":"Zhou","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"117111","DOI":"10.1016\/j.envres.2023.117111","article-title":"Site-specific delivery of cisplatin and paclitaxel mediated by liposomes: a promising approach in cancer chemotherapy","volume":"238","author":"Zou","year":"2023","journal-title":"Environ. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1745590\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:13:18Z","timestamp":1771924398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1745590\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":125,"alternative-id":["10.3389\/fphar.2026.1745590"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1745590","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"article-number":"1745590"}}